Related Experiment Video
Updated: Jan 8, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
Published on: April 25, 2025
Gastrointestinal cancer depresses immune response, yet specific anti-tumour immunity exists. Immunotherapy shows promise for gastrointestinal neoplasms, pending controlled trials and combined treatments.
Area of Science:
- Oncology
- Immunology
- Gastroenterology
Background:
- Gastrointestinal cancer is associated with a general depression of the immune response.
- Immune response depression correlates with the stage of gastrointestinal cancer.
- Specific immune responses against tumour antigens can be detected in patients.
Purpose of the Study:
- To review tumour immunology in the context of the gut.
- To analyze the complexities of immune response depression and specific anti-tumour immunity.
- To evaluate the potential of immunotherapy for gastrointestinal tumours.
Main Methods:
- Literature review focusing on tumour immunology and gastrointestinal cancer.
- Analysis of cellular and humoral immune mechanisms against tumour antigens.
- Evaluation of existing immunotherapy applications in gastrointestinal tumours.
Main Results:
- A general depression of the immune response is evident in gastrointestinal cancer patients.
- The severity of immune depression correlates with the stage of the disease.
- Both cellular and humoral immune responses against tumour antigens are demonstrable, indicating a complex paradox.
Conclusions:
- Gastrointestinal neoplasms may respond to immunotherapy similarly to other tumour types.
- Further analysis is required to understand the paradox of immune depression and specific anti-tumour immunity.
- Controlled trials investigating immunotherapy, particularly in combination with other treatments, are needed for firm conclusions.
Related Concept Videos
05:12Murine Nasal Lavage Fluid Collection without Blood Contamination
03:40Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
04:35Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
08:47Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
07:15Intranasal Administration of CNS Therapeutics to Awake Mice

